Moab Capital Partners’s Celgene Corp CELG Stock Holding History

Moab Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-187,299	Closed	-$18.6M	–	31
2019 Q3	$18.6M	Buy	187,299 +94,780	+102%	+$9.01M	7.08%	5
2019 Q2	$8.55M	Buy	92,519 +8,952	+11%	+$850K	2.78%	12
2019 Q1	$7.88M	Buy	+83,567	New	+$7.31M	1.87%	16

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Moab Capital Partners's CELG Position: Q4 2019 in Review

Moab Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 187,299 shares — an estimated $18.6M sold.

Moab Capital Partners first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $18.6M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Moab Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Moab Capital Partners sold 187,299 Celgene Corp shares in Q4 2019, an estimated $18.6M.
Moab Capital Partners first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Moab Capital Partners's Celgene Corp position peaked at $18.6M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Moab Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.